Route 92 Medical
Route 92 Medical: Pioneering neuro-interventional technology for stroke treatment since 2015.
Founded
2015Route 92 Medical: Pioneering neuro-interventional technology for stroke treatment since 2015.
Founded in 2015, Route 92 Medical is a privately held, commercial-stage medical technology company based in San Mateo, CA. The company is dedicated to pioneering neuro-interventional technology specifically for stroke treatment. Their core mission is to become the performance leader in neuroIntervention, aiming to significantly improve patient outcomes. Route 92 Medical offers innovative products such as the FreeClimb® System and Monopoint® System, which are designed to refine access and transform intervention in neurovascular procedures.
Notable affiliated individuals include experienced leaders in the medical technology field, though specific names are not provided. The company has garnered attention from investors focused on advancing medical technologies. Key achievements include the development and commercialization of their proprietary systems, which have shown promising clinical evidence in improving stroke treatment. Route 92 Medical's impact lies in its commitment to advancing neurovascular intervention, thereby enhancing the quality of care for stroke patients.
Companies similar to Route 92 Medical include Progressive Nuero, Cognition Medical, Mivi Neuroscience and Rapidpulse.
Route 92 Medical was founded in 2015.
Route 92 Medical's headquarters is located in San Mateo, CA, US.
Route 92 Medical's most recent funding round was for $31M (USD) in November 2023.
As of Nov 16, 2023, Route 92 Medical has disclosed funding of $171.5M (USD). Undisclosed round amounts are excluded.
Route 92 Medical has 70 employees as of Feb 5, 2024.
Rapidpulse
rapidpulsemed.com
